Primary Sclerosing Cholangitis

Primary sclerosing cholangitis is a chronic liver disease characterized by inflammation, scarring, and narrowing of the bile ducts inside and outside the liver. As the ducts narrow, bile flow is impaired, liver damage accumulates, and fibrosis, cirrhosis, and liver failure may develop over time. The disease is rare and may remain silent initially in many patients. For that reason, it is sometimes detected through abnormal routine liver tests. ^[1][2][3]

PSC should be distinguished from primary biliary cholangitis. Both are cholestatic liver diseases, but the bile duct structures they affect and their disease patterns are different. In PSC, irregular strictures and dilatations may be seen in both large and small bile ducts. Another important feature is its strong association with inflammatory bowel disease, especially ulcerative colitis. This relationship matters both during diagnosis and in long-term follow-up. ^[1][2][4]

What are the symptoms?

Many people have no symptoms at the beginning. When symptoms occur, fatigue, itching, jaundice, abdominal pain, and sometimes fever are among the most common. When cholangitis develops, chills, fever, and significant abdominal pain may appear. In some patients, diarrhea or symptoms related to bowel disease are more prominent. Symptom severity does not always parallel disease stage, so laboratory and imaging findings remain important in follow-up. ^[1][2][3]

In PSC, impaired bile flow can lead to deficiencies of fat-soluble vitamins, impaired bone health, and, in advanced stages, complications of cirrhosis. Recurrent cholangitis attacks can also markedly reduce quality of life. In some patients, the first clue is unexplained elevation of alkaline phosphatase. Therefore, it is not a disease recognized only after jaundice develops. ^[2][3][5]

What causes it, and which diseases is it associated with?

The exact cause of PSC is unknown. Autoimmune tendency, genetic susceptibility, and environmental factors are all thought to contribute. The most striking association is with inflammatory bowel disease, especially ulcerative colitis. Conversely, when PSC is diagnosed, evaluation of the bowel is also important, because associated bowel disease may be present even if intestinal symptoms are not obvious. ^[1][2][6]

This relationship means that PSC should be viewed not only as a liver disease but as a systemic condition requiring multidisciplinary management. In addition, risk of bile duct cancer and colorectal cancer may be increased in some patients. For this reason, follow-up is not limited to checking liver enzymes; screening and endoscopic planning are also part of long-term care. ^[1][2][7]

How is the diagnosis made?

History, physical examination, liver tests, and imaging are used together for diagnosis. MRCP—magnetic resonance cholangiopancreatography—is an important method for demonstrating the characteristic pattern of strictures and dilatations in the bile ducts. In some situations, ERCP may be used for both diagnostic and therapeutic purposes, but it is not required as a routine first test in every patient. Liver biopsy may be necessary in selected cases, especially to evaluate small-duct PSC or coexisting liver disease. ^[1][2][5]

Differential diagnosis includes bile duct stones, tumors, postsurgical strictures, IgG4-related disease, and other cholestatic liver disorders. Once the diagnosis is clarified, colonoscopy for inflammatory bowel disease evaluation, bone health assessment, and surveillance strategies for certain cancers come to the forefront. Diagnosis therefore marks the beginning of a long follow-up process. ^[2][6][7]

What do treatment and follow-up involve?

At present, there is no proven medication that definitively cures PSC. Management focuses on symptom control, treatment of bile duct strictures, prevention of complications, and assessment for liver transplantation at the appropriate time. Symptomatic therapies may be used for itching. If a dominant stricture is identified, interventions such as dilation or stenting with ERCP may be considered. Cholangitis attacks require antibiotics and prompt evaluation. ^[1][2][7]

Liver transplantation is an important treatment option for selected patients with advanced liver failure, recurrent severe cholangitis, or severe impairment of quality of life. However, not every patient with PSC requires transplantation. The course is highly individual, which is why regular hepatology follow-up is essential. If inflammatory bowel disease is also present, integrated follow-up with gastroenterology is needed as well. ^[1][2][3]

What should patients pay attention to in daily life?

Limiting or stopping alcohol, maintaining balanced nutrition, protecting bone health, reviewing vaccination status, and keeping follow-up appointments are important. The combination of abdominal pain, jaundice, and fever may suggest bile duct infection and requires urgent evaluation. Symptoms such as blood in the stool, unexplained weight loss, or a change in bowel habits are also important because of the possibility of associated intestinal disease. ^[1][2][6]

Even if PSC remains silent for a long time, follow-up should be taken seriously. New jaundice, fever, chills, abdominal swelling, bleeding, or mental status changes all require urgent attention. This content does not replace individualized diagnosis; in patients with suspected or established PSC, hepatology evaluation and, when needed, gastroenterology assessment for inflammatory bowel disease are important. ^[1][2][7]

Which complications are monitored during follow-up?

In PSC follow-up, checking liver enzymes alone is not enough. Planned surveillance is needed for bile duct infections, dominant strictures, deficiencies of fat-soluble vitamins, bone loss, and certain cancer risks. If ulcerative colitis is present, colonoscopy intervals become especially important. This multidimensional follow-up may feel burdensome, but early detection of complications can improve both quality of life and long-term outcomes. Keeping follow-up appointments is therefore an active part of treatment, not a passive one. ^[2][5][6]

FAQ

Is primary sclerosing cholangitis the same as primary biliary cholangitis?
No. They are different cholestatic liver diseases and differ in the bile duct structures involved and in follow-up characteristics. ^[1][2][3]

What are the most common symptoms in PSC?
Fatigue, itching, jaundice, abdominal pain, and in some cases fever may occur. However, symptoms may be absent initially. ^[1][2][3]

Is there a relationship with ulcerative colitis?
Yes. PSC has a strong association with inflammatory bowel disease, particularly ulcerative colitis. ^[1][2][6]

Is there a definitive cure for PSC?
At present, there is no proven medication that completely eliminates the disease. Treatment mainly targets symptoms and complications. ^[2][7]

When is urgent help needed?
The combination of fever, jaundice, and abdominal pain may suggest cholangitis and requires urgent evaluation. ^[1][2][7]